Bacterial DNA and DNA synthesis machinery

Bacterial DNA and the associated DNA synthesis machinery in anaerobic bacteria serve as the primary therapeutic target for the nitroimidazole class of antibiotics, such as metronidazole (StatPearls, 2023: https://www.ncbi.nlm.nih.gov/books/NBK539728/). In the low-oxygen environment characteristic of anaerobic metabolism, these drugs act as prodrugs that are activated via reduction by low-redox-potential electron transport proteins, such as ferredoxin or flavodoxin (PubMed, 2017: https://pubmed.ncbi.nlm.nih.gov/28536135/). The resulting short-lived, highly reactive nitro radical intermediates cause extensive damage to the bacterial DNA, including strand breakage and loss of helical structure, which leads to the inhibition of DNA synthesis and subsequent bacterial cell death (PubChem, 2024: https://pubchem.ncbi.nlm.nih.gov/compound/Metronidazole). This target is highly specific to anaerobic organisms because aerobic cells generally lack the reductive environment required to activate the drug, providing a significant therapeutic window (PMC, 2010: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851145/). Clinically, targeting this machinery is vital for treating infections caused by obligate anaerobes like Bacteroides fragilis and Clostridioides difficile, as well as certain protozoan parasites (StatPearls, 2023: https://www.ncbi.nlm.nih.gov/books/NBK539728/).

Other names

Bacterial DNADNA replication machineryAnaerobic DNA synthesis complexDNA synthesis machinery in anaerobic bacteria

Reductive activation to form reactive nitro radicals that cause DNA strand breakage and inhibit DNA synthesis